Literature DB >> 16159096

Recurrent artery-to-artery embolism during intravenous t-PA therapy for acute ischemic stroke.

Christopher D Anderson1, Deborah L Bergman, Richard A Bernstein.   

Abstract

INTRODUCTION: Treatment of acute ischemic stroke with systemic thrombolysis in the presence of a proximal thrombo-embolic source carries a theoretical risk of thrombus fragmentation and recurrent embolization. Intracardiac thrombus has received the most attention as a potential source of recurrent emboli, and in the past, it was considered a relative contra-indication to tissue plaminogen activator (t-PA) treatment. More recent data show that recurrent embolization from a cardiac source during t-PA infusion is rare. CASE REPORT: This article describes recurrent symptomatic basilar artery embolization during t-PA infusion from acute thrombus in the proximal cervical vertebral artery. DISCUSSION: This case provides evidence that intravenous t-PA must be used cautiously in the presence of large proximal thrombo-embolic sources and that intraluminal thrombus in a large cervical artery should be considered one such source.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159096     DOI: 10.1385/NCC:3:1:054

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  9 in total

1.  Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.

Authors:  P A Barber; J Zhang; A M Demchuk; M D Hill; A M Buchan
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

2.  Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement.

Authors:  A V Alexandrov; W S Burgin; A M Demchuk; A El-Mitwalli; J C Grotta
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

3.  Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus.

Authors:  L Derex; N Nighoghossian; M Perinetti; J Honnorat; P Trouillas
Journal:  Neurology       Date:  2001-12-11       Impact factor: 9.910

4.  Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.

Authors:  Andrei V Alexandrov; James C Grotta
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

5.  Intracranial clot dissolution is associated with embolic signals on transcranial Doppler.

Authors:  A V Alexandrov; A M Demchuk; R A Felberg; J C Grotta; D W Krieger
Journal:  J Neuroimaging       Date:  2000-01       Impact factor: 2.486

6.  Recurrent embolization during intravenous administration of tissue plasminogen activator in acute cardioembolic stroke. A case report.

Authors:  M Yasaka; T Yamaguchi; T Yonehara; H Moriyasu
Journal:  Angiology       Date:  1994-06       Impact factor: 3.619

7.  Late secondary ischemic injury in patients receiving intraarterial thrombolysis.

Authors:  Chelsea S Kidwell; Jeffrey L Saver; Sidney Starkman; Gary Duckwiler; Reza Jahan; Paul Vespa; J Pablo Villablanca; David S Liebeskind; Y Pierre Gobin; Fernando Vinuela; Jeffry R Alger
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

8.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

9.  Embolic stroke following thrombolytic therapy for myocardial infarction in a patient with preexisting ventricular thrombi.

Authors:  R E Bautista
Journal:  Stroke       Date:  1995-02       Impact factor: 7.914

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.